Cosmos Health

Cosmos Health Quick Ratio

The Quick Ratio (Acid Test) of Cosmos Health (COSM) as of Oct 23, 2026 is 0.26. In the previous year, Quick Ratio (Acid Test) was 0.64 — a change of -58.73% (lower).

Quick Ratio

0.26

YoY

-58.73%

Last updated:

Quick Ratio (Acid Test) of Cosmos Health is 2025 0.26 . Quick Ratio (Acid Test) of Cosmos Health was 2024 0.64 . It decreases by -58.73% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cosmos Health Stock analysis

What does Cosmos Health do? Cosmos Health Inc generates revenue through the importation, exportation, distribution, and sale of branded pharmaceuticals, over-the-counter medicines, and generic pharmaceuticals. The company leverages its subsidiary Amplerissimo Ltd., which provides data mining, statistical data analysis, research, and consulting services including credit risk analysis, marketing management, and business management software consulting. SkyPharm S.A., a subsidiary of Amplerissimo, trades branded and generic pharmaceutical products across the European Union member states, contributing to the company's revenue streams. Clients include sectors requiring pharmaceutical distribution, consulting services, and EU market access for medicines. Amplerissimo's services target businesses needing data-driven insights, credit management, and strategic consulting, while SkyPharm serves the European pharmaceutical market with a focus on branded and generic products. The company's revenue model combines direct product sales with specialized consulting services, catering to both domestic and international clients in the pharmaceutical industry. This dual approach allows Cosmos Health Inc to address diverse market needs through its subsidiaries and core operations. The firm's primary buyers are pharmaceutical distributors, healthcare providers, and businesses seeking consulting services for market expansion, data analysis, and credit management. Amplerissimo's consulting services support clients in sectors requiring strategic planning, while SkyPharm's trading activities serve EU-based pharmaceutical companies and distributors. Cosmos Health Inc's revenue is derived from product sales and service contracts, with no mention of additional revenue streams beyond the described operations. Cosmos Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cosmos Health stock

Quick Ratio (Acid Test) of Cosmos Health is 0.26 in 2025.

Quick Ratio (Acid Test) of Cosmos Health changed from 0.64 to 0.26, representing a -58.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Cosmos Health since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Cosmos Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cosmos Health

All Key Metrics — Cosmos Health